副腎癌術後再発に対するmitotane(o,p′‐DDD)単独投与が著明な腫よう縮小効果を得た1例

DOI

書誌事項

タイトル別名
  • Recurrent adrenocortical carcinoma with tumor reduction using mitotane (o,p'-DDD): A case report.

抄録

A 68-year-old woman with right-side lumbago was found to have a right adrenal tumor, which we resected in December 1999. The pathological diagnosis was adrenocortica adenoma. A tumor hump along the surgical incision appeared in June 2000. Needle biopsy indicated local recurrence of adrenocortical carcinoma. Mitotane therapy was started from August 2000, and tumors decreased markedly in size. Adrenocortical carcinoma is comparatively rare disease, found as a convalescence defective disease occurring in both men and women in all ages. Surgery remains the primary, definitive, single potentially curative treatment for adrenocortical carcinoma. Incomplete resection has an extremely poor prognosis. Our administration of mitotane in a case with local recurrence clearly reduced tumor size.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390282681262488192
  • NII論文ID
    130004298106
  • DOI
    10.11250/chemotherapy1995.50.186
  • ISSN
    18845886
    13407007
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ